This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/domain/vavai/projekt/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/resource/domain/vavai/subjekt/
n10http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
n5http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023752%3A_____%2F11%3A00001143%21RIV12-MZ0-00023752/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n13http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n20http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n18http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023752%3A_____%2F11%3A00001143%21RIV12-MZ0-00023752
rdf:type
n10:Vysledek skos:Concept
rdfs:seeAlso
http://biomed.papers.upol.cz/pdfs/bio/2011/01/14.pdf
dcterms:description
Backround. The treatment of personality disorder is repeatedly reported as less successful than the treatment of patients without personality disorder. Most clinicians believe that anxiety disorder in tandem with a personality disorder often leads to longer treatment, worsens the prognosis, and thus increases treatment costs. Our study was designed to compare the short-term effectiveness of therapy in patients suffering from social phobia with and without personality disorder. Method. The specific aim of the study was to assess the efficacy of a 6 week therapeutic program designed for social phobia (SSRIs and CBT) in patients suffering from social phobia with comorbid personality disorder (17 patients) and social phobia without comorbid personality disorder (18 patients). The patients were regularly assessed in weeks 0, 2, 4 and 6 using the CGI (Clinical Global Improvement) for severity, LSAS (Liebowitz Social Anxiety Scale), and in self-assessments BAI (Beck Anxiety Inventory) and BDI (Beck Depression Inventory). Results. Patients in both groups improved their scores in most of the assessment instruments used. A combination of CBT and pharmacotherapy proved to be the most effective treatment for patients suffering with social phobia with or without comorbid personality disorder. Treatment efficacy in patients with social phobia without personality disorder was significantly better than in the group with social phobia comorbid with personality disorder for CGI and specific inventory for social phobia - LSAS. The scores on the subjective depression inventory (BDI) also showed significantly greater decrease over the treatment in the group without personality disorder. The treatment effect between groups did not differ in subjective general anxiety scales BAI. Conclusion. Our study showed that patients suffering from social phobia and comorbid personality disorder showed a smaller decrease in specific social phobia symptomatology during treatment compared than pa Backround. The treatment of personality disorder is repeatedly reported as less successful than the treatment of patients without personality disorder. Most clinicians believe that anxiety disorder in tandem with a personality disorder often leads to longer treatment, worsens the prognosis, and thus increases treatment costs. Our study was designed to compare the short-term effectiveness of therapy in patients suffering from social phobia with and without personality disorder. Method. The specific aim of the study was to assess the efficacy of a 6 week therapeutic program designed for social phobia (SSRIs and CBT) in patients suffering from social phobia with comorbid personality disorder (17 patients) and social phobia without comorbid personality disorder (18 patients). The patients were regularly assessed in weeks 0, 2, 4 and 6 using the CGI (Clinical Global Improvement) for severity, LSAS (Liebowitz Social Anxiety Scale), and in self-assessments BAI (Beck Anxiety Inventory) and BDI (Beck Depression Inventory). Results. Patients in both groups improved their scores in most of the assessment instruments used. A combination of CBT and pharmacotherapy proved to be the most effective treatment for patients suffering with social phobia with or without comorbid personality disorder. Treatment efficacy in patients with social phobia without personality disorder was significantly better than in the group with social phobia comorbid with personality disorder for CGI and specific inventory for social phobia - LSAS. The scores on the subjective depression inventory (BDI) also showed significantly greater decrease over the treatment in the group without personality disorder. The treatment effect between groups did not differ in subjective general anxiety scales BAI. Conclusion. Our study showed that patients suffering from social phobia and comorbid personality disorder showed a smaller decrease in specific social phobia symptomatology during treatment compared than pa
dcterms:title
Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia? Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia?
skos:prefLabel
Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia? Is there any influence of personality disorder on the short term intensive group cognitive behavioral therapy of social phobia?
skos:notation
RIV/00023752:_____/11:00001143!RIV12-MZ0-00023752
n10:predkladatel
n15:ico%3A00023752
n4:aktivita
n8:P n8:I
n4:aktivity
I, P(NS9752)
n4:cisloPeriodika
1
n4:dodaniDat
n18:2012
n4:domaciTvurceVysledku
n6:7625952 n6:5954487 n6:8426988 n6:5070716
n4:druhVysledku
n20:J
n4:duvernostUdaju
n19:S
n4:entitaPredkladatele
n5:predkladatel
n4:idSjednocenehoVysledku
205889
n4:idVysledku
RIV/00023752:_____/11:00001143
n4:jazykVysledku
n11:eng
n4:klicovaSlova
social phobia; personality disorders; controlled study; cognitive-behavioral; antidepressants
n4:klicoveSlovo
n7:antidepressants n7:social%20phobia n7:personality%20disorders n7:cognitive-behavioral n7:controlled%20study
n4:kodStatuVydavatele
CZ - Česká republika
n4:kontrolniKodProRIV
[BA2AE11C6A91]
n4:nazevZdroje
Biomedical Papers-Olomouc
n4:obor
n16:FL
n4:pocetDomacichTvurcuVysledku
4
n4:pocetTvurcuVysledku
4
n4:projekt
n17:NS9752
n4:rokUplatneniVysledku
n18:2011
n4:svazekPeriodika
155
n4:tvurceVysledku
Praško, Ján Vyskočilová, Jana Pohlová, Libuše Novák, Tomáš
n4:wos
000288766200014
s:issn
1213-8118
s:numberOfPages
10
n13:doi
10.5507/bp.2011.005